AllianzIM U.S. Large Cap Buffer20 Feb ETF (FEBW)

On our options desk, we are closely tracking FEBW's layered FLEX options structure tied to SPY. With the VIX spiking toward the 45-50 range in early April 2026, the cap-reset for the upcoming outcome period is widening, providing a unique calibration for clients who entered at inception versus those buying mid-period.

From a market positioning standpoint, the institutional sponsorship here is undeniable. SEC 13F filings for Q2 2026 show 48 reporting managers holding 3.2M shares worth $111.5M, representing about 96.1% of shares outstanding. Even Allianz itself boosted its position by 23% in Q2, bringing its stake to 191,866 shares valued at $6.82M.

As a risk manager evaluating defined-outcome sleeves, I look at the 3-year beta of 0.41 and the worst drawdown of -3.5% against the SandP's -9.3%. The downside buffer mandate clearly functions as designed, but the 3-year Sharpe ratio of 0.97 trailing the category median of 1.00 reminds us that protection always extracts a heavy toll on upside capture.

Watching the liquidity metrics on FEBW is critical before execution. With an AUM of roughly $197 million but an average daily dollar volume hovering around $22,800, retail exit friction can be severe if positions are sized too large relative to the order book, despite the 30-day median bid-ask spread sitting at 0.20%.

In our macro asset allocation calls, we note that the underlying SandP 500 carries a P/E of 20.70x, which sits slightly below the category average of 21.19x but above comparison indices. Combined with tariff escalation and growth deceleration fears in 2026, clients utilizing FEBW's February-to-February outcome period must accept that mid-period entry points skew headline payoff assumptions.